ARTICLE | Clinical News
Supratek begins esophagus cancer Phase II
November 15, 2001 8:00 AM UTC
Supratek (Montreal, Quebec) began an open-label, U.K. Phase II trial of its SP1049C biotransport carrier version of doxorubicin to treat adenocarcioma of the esophagus. ...